Support and Resistance Levels
Past performance
About Alembic Pharmaceuticals Ltd Alembic Pharmaceuticals, established in 2010, is a prominent global player in the generic pharmaceuticals industry, with advanced research and manufacturing facilities approved by leading regulatory authorities, including the US FDA. Initially a wholly-owned subsidiary of Alembic Ltd, the company transitioned to an independent associate in 2011 and later became publicly listed on the Bombay and National Stock Exchanges. Alembic is a leader in branded generics in India and has expanded its global footprint through strategic partnerships and acquisitions.
The company has actively pursued international markets, notably establishing a subsidiary in Chile and a scientific office in the UAE to capitalize on opportunities in Latin America and the GCC. Alembic's oncology manufacturing facility in Gujarat, approved by the US FDA, supports its extensive portfolio of 245 ANDAs. The company continues to innovate, with recent product launches focusing on gynecology and anti-diabetic therapies, and maintains a strong commitment to expanding its specialty therapeutic offerings.